Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
39000 participants
OBSERVATIONAL
2021-07-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Training-action About Projects Leading for the Improvement of Care Quality in Managing Practice of Health Executive
NCT02869711
Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients
NCT07093450
Family Satisfaction (FS) in the Intensive Care Unit
NCT01449734
Written Communication in the Intensive Care Unit
NCT05636371
Integrating the Fundamentals of Care Framework Into Italian Nursing Education
NCT05177627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eligible population
All patients admitted in the semi-intensive care units attending the study. Be basing on the average number of patients yearly treated in those units, we expect to have at least 39000 patients during the 5 years of the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mario Negri Institute for Pharmacological Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Milan, Milan, Italy
ASO SS Antonio e Biagio e Cesare Arrigo
Alessandria, , Italy
Ospedale Umberto Parini
Aosta, , Italy
Ospedale San Bassiano
Bassano del Grappa, , Italy
Ospedale Maggiore
Bologna, , Italy
AOU Policlinico S. Marco
Catania, , Italy
AOU Policlinico San Marco
Catania, , Italy
Ospedale Bufalini
Cesena, , Italy
Ospedale Santa Maria Annunziata
Florence, , Italy
Ospedale Morgagni-Pierantoni
Forlì, , Italy
Ospedale Palmanova-Latisana
Latisana, , Italy
Ospedali Riuniti
Livorno, , Italy
ASST Lodi
Lodi, , Italy
Ospedale Santa Maria delle Grazie
Napoli, , Italy
AOU San Luigi Gonzaga
Orbassano, , Italy
Ospedale Guglielmo da Saliceto
Piacenza, , Italy
Ospedale E.Agnelli
Pinerolo, , Italy
AOU Pisana
Pisa, , Italy
Ospedale Santa Maria delle Croci
Ravenna, , Italy
Ospedale Sant'Eugenio
Roma, , Italy
AOU di Sassari
Sassari, , Italy
Ospedale Giovanni Bosco
Torino, , Italy
Ospedale Ca' Foncello
Treviso, , Italy
Santa Maria della Misericordia
Udine, , Italy
Ospedale Michele e Pietro Ferrero
Verduno, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRFMN_7998
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.